400802-95-1

Upstream product

• 217807-98-2 4-morpholin-4-yl-3,6-dihydro-2H-pyridine-1-carboxylic acid ter-tbutyl ester 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 
• 106-89-8 epichlorohydrin 
• 400802-94-0 3-(4-iodophenyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxylic acid tert-butyl ester 

Downstream Products

• 400804-05-9 1-[2-hydroxy-3-(4-(o-tolyl)piperazin-2-yl)propyl]-3-(4-iodophenyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxylic acid tert-butyl ester 
• 400802-50-8 1-{3-[4-(2-cyanophenyl)piperazin-1-yl]-2-hydroxypropyl}-3-(4-iodophenyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxylic acid tert-butyl ester 
• 400804-32-2 1-[3-(4-iodophenyl)-4,5,6,7-tetrahydropyrazolo[4,3-c]pyridin-1-yl]-3-(4-(o-tolyl)piperazin-1-yl)propan-2-ol 

Relevant academic research and scientific papers

Nonpeptidic, noncovalent inhibitors of the cysteine protease cathepsin S

The first nonpeptidic, noncovalent inhibitors of the cysteine protease cathepsin S (CatS) are described. Electronic database searching using the program DOCK generated a screening set of potential CatS inhibitors from which two lead structures were identi

Method for treating allergies using substituted pyrazoles

A method for treating an allergic condition, including an atopic allergic condition, using substituted pyrazoles.

Method for treating allergies using substituted pyrazoles

A method for treating an allergic condition, including an atopic allergic condition, using substituted pyrazoles.